Efficacy of Buprenorphine on Postoperative Endodontic Analgesia (EBPEA)
Primary Purpose
Postoperative Pain
Status
Terminated
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Buprenorphine
Sterile saline
lidocaine, epinephrine (Local anesthetic)
Sponsored by
About this trial
This is an interventional treatment trial for Postoperative Pain focused on measuring analgesia, endodontic, postoperative
Eligibility Criteria
Inclusion Criteria:
- persons with preoperative pain to percussion of a tooth with pulpal disease requiring endodontic therapy, healthy individuals, ASA Class I and II, no known allergies to the drugs being administered
Exclusion Criteria:
- pregnancy, allergy to buprenorphine, allergy to local anesthetic
Sites / Locations
- University Hospitals Cleveland Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
buprenorphine and local anesthetic
sterile saline and local anesthetic
Arm Description
buprenorphine added to local anesthetic
sterile saline (placebo) added to local anesthetic
Outcomes
Primary Outcome Measures
The Efficacy of Buprenorphine in addition to Local Anesthetic in Providing Prolonged Postoperative Endodontic Analgesia
The number of patients with extended postoperative analgesia when compared to the baseline in pain scores on a visual analog scale during a three-day period will be analyzed. A questionnaire containing a visual analog scale and a log for recording the use of rescue analgesics will be used to gather the data.
Secondary Outcome Measures
Full Information
NCT ID
NCT03268278
First Posted
August 11, 2017
Last Updated
April 19, 2019
Sponsor
University Hospitals Cleveland Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT03268278
Brief Title
Efficacy of Buprenorphine on Postoperative Endodontic Analgesia
Acronym
EBPEA
Official Title
Efficacy of Buprenorphine on Postoperative Endodontic Analgesia
Study Type
Interventional
2. Study Status
Record Verification Date
April 2019
Overall Recruitment Status
Terminated
Why Stopped
Loss of interest
Study Start Date
April 1, 2017 (Actual)
Primary Completion Date
July 1, 2018 (Actual)
Study Completion Date
July 1, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospitals Cleveland Medical Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
To see whether the addition of buprenorphone to local anesthesia will lengthen postoperative analgesia for endodontic pain
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Pain
Keywords
analgesia, endodontic, postoperative
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
10 (Actual)
8. Arms, Groups, and Interventions
Arm Title
buprenorphine and local anesthetic
Arm Type
Active Comparator
Arm Description
buprenorphine added to local anesthetic
Arm Title
sterile saline and local anesthetic
Arm Type
Placebo Comparator
Arm Description
sterile saline (placebo) added to local anesthetic
Intervention Type
Drug
Intervention Name(s)
Buprenorphine
Intervention Description
Buprenorphine plus local anesthetic
Intervention Type
Drug
Intervention Name(s)
Sterile saline
Intervention Description
Placebo 1,8 ml
Intervention Type
Drug
Intervention Name(s)
lidocaine, epinephrine (Local anesthetic)
Intervention Description
2% lidocaine 1:100,000 epinephrine
Primary Outcome Measure Information:
Title
The Efficacy of Buprenorphine in addition to Local Anesthetic in Providing Prolonged Postoperative Endodontic Analgesia
Description
The number of patients with extended postoperative analgesia when compared to the baseline in pain scores on a visual analog scale during a three-day period will be analyzed. A questionnaire containing a visual analog scale and a log for recording the use of rescue analgesics will be used to gather the data.
Time Frame
two years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
persons with preoperative pain to percussion of a tooth with pulpal disease requiring endodontic therapy, healthy individuals, ASA Class I and II, no known allergies to the drugs being administered
Exclusion Criteria:
pregnancy, allergy to buprenorphine, allergy to local anesthetic
Facility Information:
Facility Name
University Hospitals Cleveland Medical Center
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44106
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Efficacy of Buprenorphine on Postoperative Endodontic Analgesia
We'll reach out to this number within 24 hrs